Detecting p16 Methylation in Oral Tissues
Author Information
Author(s): Zhou Jing, Cao Jie, Lu Zheming, Liu Hongwei, Deng Dajun
Primary Institution: Peking University Cancer Hospital & Institute
Hypothesis
p16 methylation is a potential biomarker for predicting malignant transformation of epithelial dysplasia.
Conclusion
The 115-bp MethyLight assay is a useful and practical assay with very high specificity for the detection of p16 methylation clinically.
Supporting Evidence
- Methylated-p16 was detected in 75 of 102 tested samples.
- The 115-bp MethyLight assay showed a very high specificity of 98.3%.
- Among patients aged 60 and above, 75% of those with methylated-p16 developed oral cancer.
Takeaway
Scientists developed a test to find a specific marker in tissues that can help predict if a person might develop cancer.
Methodology
The study analyzed oral mucosa biopsies from patients using two MethyLight assays to detect p16 methylation.
Limitations
The study may have limitations related to the sample size and the specificity of the assays used.
Participant Demographics
Patients with oral mucosa dysplasia, including those aged 60 and above.
Statistical Information
P-Value
P=0.000
Confidence Interval
95% CI: 0.677-0.874
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website